- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02096783
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
Randomized-Controlled, Pilot Study of the Effects of a Brief, Scripted Sexual Health Intervention on Sexual Function for Women With Gynecologic Cancer
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
PRIMARY OBJECTIVES:
I. To evaluate the feasibility of patient recruitment, including time required to consent, enroll and retain the necessary number of participants.
II. To determine the distribution of candidate primary patient-reported outcome measures, including time to resumption of sexual activity, global satisfaction with sex life, sexual function and anxiety in this particular population.
III. To establish the prevalence of patient recall of the intervention to determine the most effective time at which to deliver the intervention.
OUTLINE: Patients are randomized to 1 of 4 treatment arms.
ARM I: Patients receive standard counseling at both the pre-operative and 2-4 week post-operative visit.
ARM II: Patients receive standard counseling at the pre-operative visit and the scripted sexual health intervention at the 2-4 week post-operative visit.
ARM III: Patients receive standard counseling and the scripted sexual health intervention at the pre-operative visit and standard counseling at the 2-4 week post-operative visit.
ARM IV: Patients receive standard counseling and the scripted sexual health intervention at both the pre-operative and 2-4 week post-operative visit.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Wisconsin
-
Madison, Wisconsin, Forente stater, 53792
- University of Wisconsin, Madison
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients with a new suspected or confirmed gynecologic malignancies
- Patients plan to have primary surgery at either the University of Chicago Hospital or the University of Wisconsin Hospital
- Patients must be English speaking
Exclusion Criteria:
- Previous treatment of any cancer excluding skin cancer
- Patients with a suspected benign gynecologic process
- Patients who are prisoners or incarcerated
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Arm I (standard counseling)
Patients receive standard counseling at both the pre-operative and 2-4 week post-operative visit.
|
Hjelpestudier
Given standard counseling
Andre navn:
|
|
Eksperimentell: Arm II (standard counseling, scripted intervention)
Patients receive standard counseling at the pre-operative visit and the scripted sexual health intervention at the 2-4 week post-operative visit.
|
Hjelpestudier
Given standard counseling
Andre navn:
Given scripted intervention
|
|
Eksperimentell: Arm III (standard counseling, scripted intervention)
Patients receive standard counseling and the scripted sexual health intervention at the pre-operative visit and standard counseling at the 2-4 week post-operative visit.
|
Hjelpestudier
Given standard counseling
Andre navn:
Given scripted intervention
|
|
Eksperimentell: Arm IV (standard counseling, scripted intervention)
Patients receive standard counseling and the scripted sexual health intervention at both the pre-operative and 2-4 week post-operative visit.
|
Hjelpestudier
Given standard counseling
Andre navn:
Given scripted intervention
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility of patient recruitment
Tidsramme: Up to 9 months
|
To inform possible issues in recruitment for a large-scale randomized controlled trial, the ratio of enrolled subjects to total eligible potential subjects as well as the time necessary to recruit those subjects will be tracked.
|
Up to 9 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Resumption of sexual activity after cancer surgery
Tidsramme: Up to 9 months
|
Resumption of sexual activity after cancer surgery will be measured using items adapted from a previous national, multi-site study of sexual outcomes following an acute myocardial infarction.
|
Up to 9 months
|
|
Retention
Tidsramme: Up to 9 months
|
The percentage of subjects completing the final assessment from the total number of subjects enrolled will be calculated.
|
Up to 9 months
|
|
Satisfaction with sex life independent of specific sexual function measured by Patient Reported Outcomes Measurement Information System (PROMIS) Global Satisfaction with Sex Life questionnaire
Tidsramme: Up to 9 months
|
Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms.
|
Up to 9 months
|
|
PROMIS Sexual Function Profile
Tidsramme: Up to 9 months
|
Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms.
|
Up to 9 months
|
|
Recall of intervention
Tidsramme: Up to 9 months
|
Subjects will be queried to learn whether they recall receiving physician counseling about sexual health outcomes after surgery with follow up questions regarding whether or not the patient has spoken with other healthcare providers about sexual concerns.
|
Up to 9 months
|
|
Patient-reported anxiety measured by PROMIS Anxiety 4a short form
Tidsramme: Up to 6 months
|
Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms.
|
Up to 6 months
|
|
Rate of referral acceptance
Tidsramme: Up to 9 months
|
The rate of acceptance of sexual health clinic referrals as well as rates of utilization of these referrals will be tracked using medical record abstraction.
|
Up to 9 months
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: David Kushner, University of Wisconsin, Madison
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Psykiske lidelser
- Neoplasmer etter histologisk type
- Neoplasmer
- Urogenitale neoplasmer
- Neoplasmer etter nettsted
- Karsinom
- Neoplasmer, kjertel og epitel
- Uterine neoplasmer
- Genitale neoplasmer, kvinnelige
- Livmorsykdommer
- Sykdommer i det endokrine systemet
- Sykdommer i eggstokkene
- Adnexal sykdommer
- Gonadal lidelser
- Neoplasmer i endokrine kjertel
- Neoplasmer, kjønnsceller og embryonale
- Graviditetskomplikasjoner
- Vaginale sykdommer
- Vulva sykdommer
- Neoplasmer i eggstokkene
- Graviditetskomplikasjoner, neoplastiske
- Angstlidelser
- Endometriale neoplasmer
- Karsinom, ovarieepitel
- Vulva neoplasmer
- Trofoblastiske neoplasmer
- Vaginale neoplasmer
Andre studie-ID-numre
- UW13080 (Annen identifikator: University of Wisconsin Carbone Cancer Center)
- P30CA014520 (U.S. NIH-stipend/kontrakt)
- A532820 (Annen identifikator: UW Madison)
- SMPH/OBSTET & GYNECOL/OBSTET (Annen identifikator: UW Madison)
- NCI-2014-00471 (Registeridentifikator: NCI Trial ID)
- 2014-0122 (Annen identifikator: Institutional Review Board)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .